Table 3. BASDAI and BASFI scores in patients with IL-12B genotypes.
| SNPs | Genetype | BASDAI | BASFI |
|---|---|---|---|
| rs10045431 | A/A | 4.498 ± 1.905 | 3.826 ± 3.201 |
| C/C | 3.962 ± 1.912 | 2.891 ± 2.106 | |
| C/A | 4.154 ± 2.097 | 2.675 ± 1.707 | |
| p value | 0.557 | 0.271 | |
| p value* | 0.614 | 0.354 | |
| rs11167764 | A/A | 4.305 ± 1.079 | 4.545 ± 3.507 |
| C/C | 4.087 ± 1.995 | 2.897 ± 2.097 | |
| C/A | 3.754 ± 1.812 | 2.716 ± 1.904 | |
| p value | 0.335 | 0.203 | |
| p value* | 0.397 | 0.312 | |
| rs3212227 | A/A | 4.011 ± 1.942 | 3.023 ± 2.341 |
| C/C | 4.144 ± 2.218 | 2.882 ± 2.262 | |
| C/A | 3.959 ± 1.844 | 2.766 ± 1.782 | |
| p value | 0.786 | 0.548 | |
| p value* | 0.869 | 0.611 | |
| rs6556412 | A/A | 3.857 ± 1.968 | 2.957 ± 2.169 |
| C/C | 4.035 ± 1.912 | 2.756 ± 2.069 | |
| C/A | 4.043 ± 1.971 | 2.902 ± 2.030 | |
| p value | 0.780 | 0.755 | |
| p value* | 0.852 | 0.877 | |
| rs6556416 | A/A | 3.963 ± 1.474 | 3.656 ± 3.565 |
| C/C | 3.977 ± 1.921 | 2.901 ± 2.106 | |
| C/A | 4.154 ± 2.097 | 2.675 ± 1.707 | |
| p value | 0.775 | 0.419 | |
| p value* | 0.831 | 0.522 | |
| rs6871626 | A/A | 4.244 ± 1.713 | 3.058 ± 2.013 |
| C/C | 3.983 ± 1.931 | 2.918 ± 2.163 | |
| C/A | 3.373 ± 1.694 | 2.129 ± 1.352 | |
| p value | 0.012 | 0.023 | |
| p value* | 0.031 | 0.041 | |
| rs6887695 | G/G | 3.873 ± 1.929 | 2.641 ± 1.896 |
| C/C | 4.021 ± 1.945 | 2.984 ± 2.108 | |
| G/C | 4.054 ± 1.954 | 2.812 ± 2.085 | |
| p value | 0.829 | 0.482 | |
| p value* | 0.935 | 0.549 | |
| rs7709212 | C/C | 4.024 ± 1.882 | 2.774 ± 2.089 |
| C/T | 4.009 ± 2.140 | 3.067 ± 2.291 | |
| T/T | 4.001 ± 1.916 | 2.858 ± 1.964 | |
| p value | 0.995 | 0.612 | |
| p value* | 0.999 | 0.786 |
BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index.
* Adjusting the effects of age, sex, disease duration.